Latest News for PUDO Stock (OTC:PDPTF)

PUDO Inc is engaged in the business of parcel pick-up and drop-off services. Its principal activity is providing E-commerce shipment services through collaboration with specific online retailers for delivery of their products and working with national and international courier companies to provide alternate drop-off and pickup options for packages. Geographically, it generates revenue in Canada and the USA.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Penny Stocks

Retail Sales

Management

Events

Global

Markets

General

BTIM

CUEN

BOSSY

MHGU

GBLTF

TSXV:GBLT

POPRF

TSXV:POPR

TNYYF

NEXCF

CSE:NTAR

BBKCF

CSE:BIGG

GENTF

PDPTF

CSE:PDO

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

How 12 Consumer And Digital Goods Companies Are Navigating The Pandemic

Biotech

Commodities

ABQQ

AMMX

GRBX

HLYK

TSXV:CNC

CHXMF

TSX:TLG

PREIF

TSXV:PRG

GXSFF

TSXV:GXS

KOREF

TSXV:KORE

MDRPF

TSX:MAX

SKREF

TSXV:SKE

GLBXF

TSX:GMX

GLVMF

TSXV:GZZ

ORZCF

TSXV:ORE

NTGSF

TSXV:GPY

FFMGF

TSX:FF

WHGOF

TSXV:WGO

FRERF

TSXV:FRE

RVLGF

TSXV:RVG

DFMTF

TSXV:DEFN

TSXV:GTT

GLATF

TSX:GLO

NKOSF

TSXV:LAB

TSKFF

CSE:TSK

SLVRF

TSXV:SVE

PGEZF

TSXV:PGE

NMGRF

TSXV:NOU

SEGN

ROIUF

TSXV:ROI

IDXAF

VRSSF

CSE:VS

VYGVF

CSE:VYGR

DFLYF

CSE:DFLY

LLKKF

BFGC

CSE:BFG

MMEDF

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

The metals market is as hot as it’s been in a long time.

With Gold And Silver On Fire, 23 Metals &amp; Mining Executives Set To Give Investor Update This Week

PUDO Inc

HC Wainwright &amp; Co. analyst Raghuram Selvaraju initiates coverage on Ovid Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OVID#NASDAQ">OVID</a>) with a Buy rating and announces Price Target of $9.

Price Target

Initiation

Analyst Ratings

OVID

HC Wainwright & Co. Initiates Coverage On Ovid Therapeutics with Buy Rating, Announces Price Target of $9

Earnings

Domino's Pizza Q1 US Same Store Sales Growth +5.6%, International Same Store Sales Growth +0.9%

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ATNM#AMEX">ATNM</a>) with a Buy and maintains $50 price target.

Reiteration

ATNM

HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $50 Price Target

Domino's Pizza (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) reported quarterly earnings of $3.58 per share which beat the analyst consensus estimate of $3.42 by 4.68 percent. This is a 22.18 percent increase over earnings of $2.93 per share from the same period last year. The company reported quarterly sales of $1.085 billion which beat the analyst consensus estimate of $1.079 billion by 0.53 percent. This is a 5.96 percent increase over sales of $1.024 billion the same period last year.

Earnings Beats

Domino's Pizza Q1 2024 GAAP EPS $3.58 Beats $3.42 Estimate, Sales $1.085B Beat $1.079B Estimate

MannKind Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNKD#NASDAQ">MNKD</a>), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared the company&#39;s Investigational New Drug (IND) application for MNKD-101 (Clofazimine Inhalation Suspension), enabling the initiation of a Phase 3 study for the treatment of nontuberculous mycobacterial (NTM) lung disease.

Government

Regulations

MNKD

MannKind Announces IND Clearance From US FDA to Start Phase 3 Study of Clofazimine Inhalation Suspension for Nontuberculous Mycobacterial (NTM) Lung Disease

HC Wainwright &amp; Co. analyst Mike Colonnese maintains Coinbase Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) with a Buy and raises the price target from $250 to $300.

COIN

HC Wainwright & Co. Maintains Buy on Coinbase Glb, Raises Price Target to $300

Guidance

Health Care

RVTY

Revvity Reaffirms Its 2024 Adjusted EPS Guidance Of $4.55-$4.75 Versus Consensus Of $4.65 And Organic Growth Guidance Of 1-3%

Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) (&quot;TMTG&quot; or the &quot;Company&quot;) is highlighting actions DJT shareholders can take to prevent the lending of their shares by brokerage firms for the purpose of short selling. 
&nbsp;
The Company&#39;s shareholder base primarily consists of retail investors who hold their shares through various brokerage firms. Many of these retail shareholders invested in DJT because they support TMTG&#39;s mission to create a free-speech beachhead against Big Tech censorship.
TMTG wants to clarify that if shares are currently on loan by brokerage firms to facilitate short selling, shareholders have the option of asking their broker to recall their shares.
After recalling their shares, long-term shareholders who believe in the Company&#39;s future can then hold their DJT shares in a cash account, opt out of any securities lending programs, or move their shares to a Direct Registration (&quot;DRS&quot;) account at the Company&#39;s transfer agent, Odyssey Transfer &amp; Trust Company.
Form of Letter to Broker
If investors decide to instruct their broker not to make their shares available for lending, the following is a sample of the language they can use in their email or letter to the Branch Manager of their brokerage account:
[Broker Name]
[Broker Address]
Attn: Branch Manager
My Account [Account Number]
Dear Sir or Madam:
Please accept this written instruction to make sure that the following securities are held in my cash account only and accordingly are not available for any stock loan activities. I hereby expressly opt-out of any securities lending programs and instruct you to not loan out any of my shares.&nbsp;Additionally, as applicable, please recall any shares that are currently on loan.
Securities:
[Number] shares of Trump Media &amp; Technology Group Corp. (DJT) and any DJT shares subsequently acquired.
Please confirm receipt and compliance with this request.
Additional Information Regarding Moving Shares Out of Brokerage Accounts
Please note that investors may incur certain costs in connection with transferring shares out of a brokerage account and, once their shares are moved to our transfer agent, their ability to timely transfer their shares back to a brokerage firm and sell may be a longer process. Holding shares in physical certificate form involves risk of loss or destruction where a bond of indemnity is required to replace the certificate(s).

Short Sellers

Trump Media & Technology Group Urges Shareholders to Recall Shares to Combat Short Selling

BBVA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBVA#NYSE">BBVA</a>) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.35 by 14.86 percent. This is a 29.68 percent increase over earnings of $0.31 per share from the same period last year. The company reported $8.925 billion in sales this quarter. This is a 19.51 percent increase over sales of $7.468 billion the same period last year.

BBVA

BBVA Q1 2024 Adj EPS $0.40 Beats $0.35 Estimate, Sales $8.925B Up From $7.468B YoY

ARLP

Alliance Resource Partners Reiterates Full-year Guidance With Operations Running As Expected Year-To-Date And Well-Contracted Order Book

Revvity Revises 2024 Revenue Forecast To $2.76B-$2.82B From Prior Guidance Of $2.79B-$2.85B Versus Consensus Of $2.81B

A real estate fund managed by Kennedy Wilson has partnered with Haseko Corporation to acquire The Farmstead and Villas at 28th Street communities in Vancouver, Washington. The portfolio, which totals 350 multifamily units, was acquired for&nbsp;$90 million. The two newly constructed, amenity rich communities build on Kennedy Wilson&#39;s significant multifamily presence in the Pacific Northwest that is currently approaching 13,000 market rate and affordable apartment units.

Kennedy Wilson and Haseko Acquire Two Multifamily Communities in Vancouver, Washington for $90M

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Galiano Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GAU#AMEX">GAU</a>) with a Buy and raises the price target from $2.2 to $4.3.

HC Wainwright & Co. Maintains Buy on Galiano Gold, Raises Price Target to $4.3

Provident Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROV#NASDAQ">PROV</a>) reported quarterly earnings of $0.22 per share which missed the analyst consensus estimate of $0.23 by 4.35 percent. This is a 33.33 percent decrease over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $9.407 million which missed the analyst consensus estimate of $9.730 million by 3.32 percent. This is a 9.39 percent decrease over sales of $10.382 million the same period last year.

Earnings Misses

PROV

Provident Finl Hldgs Q3 2024 GAAP EPS $0.22 Misses $0.23 Estimate, Sales $9.407M Miss $9.730M Estimate

Repertoire&reg;&nbsp;Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell targeted immune medicines, announced today that it has entered a multi-year strategic collaboration with Bristol Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) to develop tolerizing vaccines for up to three autoimmune diseases. The collaboration aims to develop efficacious, selective, and durable treatments for patients suffering from autoimmune disease by resetting the immune system.
Under the terms of the agreement, Repertoire will receive an upfront payment of&nbsp;$65 million, and up to&nbsp;$1.8 billion&nbsp;for achieving development, regulatory and commercial milestones in addition to receiving tiered royalties.

Bristol Myers Squibb and Repertoire Announce $1.8B Deal to Reset Immune System in Autoimmune Patients

Alliance Res Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARLP#NASDAQ">ARLP</a>) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.02 by 18.63 percent. This is a 16.55 percent decrease over earnings of $1.45 per share from the same period last year. The company reported quarterly sales of $651.697 million which beat the analyst consensus estimate of $620.061 million by 5.10 percent. This is a 1.69 percent decrease over sales of $662.922 million the same period last year.

Alliance Res Partners Q1 2024 GAAP EPS $1.21 Beats $1.02 Estimate, Sales $651.697M Beat $620.061M Estimate

Revvity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVTY#NYSE">RVTY</a>) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.93 by 5.38 percent. This is a 2.97 percent decrease over earnings of $1.01 per share from the same period last year. The company reported quarterly sales of $649.920 million which beat the analyst consensus estimate of $646.843 million by 0.48 percent. This is a 3.70 percent decrease over sales of $674.865 million the same period last year.

Revvity Q1 2024 Adj EPS $0.98 Beats $0.93 Estimate, Sales $649.920M Beat $646.843M Estimate

TD Cowen analyst Tara Bancroft initiates coverage on Geron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) with a Buy rating and announces Price Target of $10.

GERN

TD Cowen Initiates Coverage On Geron with Buy Rating, Announces Price Target of $10

Shares of Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) rose sharply in today's pre-market trading after reporting first-quarter results. The company also resolved the respironics personal injury and medical monitoring litigation in the US <a href="https://www.benzinga.com/quote/PHG/earnings">for $1.1 billion</a>.
Koninklijke Philips shares jumped 37.1% to $28.87 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Inno Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INHD#NASDAQ">INHD</a>) gained 33.8% to $0.8410 in pre-market trading.</li>
<li>Ryde Group Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#NYSE">RYDE</a>) gained 25.9% to $4.18 in pre-market trading after dipping 8% on Friday.</li>
<li>Akanda Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) climbed 21.4% to $0.1250 in pre-market trading after gaining over 12% on Friday.</li>
<li>Ocean Biomedical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCEA#NASDAQ">OCEA</a>) rose 15.7% to $1.55  in today's pre-market trading after gaining 7% on Friday.</li>
<li>Wisekey International Holding AG &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKEY#NASDAQ">WKEY</a>) shares rose 15.2% to $2.36 in pre-market trading. WISeSAT.Space, a subsidiary of WISeKey International, announced the strengthening of its strategic partnership with the Swiss Armed Forces in the space sector for 2024 and beyond.</li>
<li>SolarBank Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUUN#NASDAQ">SUUN</a>) shares gained 14.1% to $6.78 in pre-market trading.</li>
<li>Fulton Financial Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULT#NASDAQ">FULT</a>) jumped 10.8% to $17.30 in pre-market trading. Republic First Bancorp has been seized by U.S. regulators and sold to Fulton Bank, a unit of Fulton Financial Corp.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) shares gained 10.6% to $8.13 in pre-market trading. ImmunityBio shares jumped around 44% on Friday after the company announced overall survival results in its QUILT 3.055 study.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares gained 7.3% to $180.54 in pre-market trading. Tesla is reportedly set to lay off 693 employees at its Nevada facilities as part of the 10% layoff announced by the company earlier this month to reduce costs amid falling EV sales and margins. The company also increased the price of its new Model 3 Performance in the U.S. by $1000, merely days after its launch.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Bakkt Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKKT#NASDAQ">BKKT</a>) fell 92.2% to $0.78 in pre-market trading. The company recently announced a 1-for-25 reverse stock split.</li>
<li>Clever Leaves Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLVR#NASDAQ">CLVR</a>) shares declined 56.8% to $1.78 in pre-market trading after the company announced voluntary delisting of common shares and SEC deregistration.</li>
<li>Addex Therapeutics Ltd  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) fell 50.3% to $7.99 pre-market trading. Addex Therapeutics announced lack of statistical significance in ADX71149 Phase 2 epilepsy study.</li>
<li>iSun, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISUN#NASDAQ">ISUN</a>) fell 18.9% to $0.1362 in pre-market trading. iSun, last week, announced rescission of reverse stock split.</li>
<li>Boqii Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BQ#NYSE">BQ</a>) fell 16.7% to $0.25 pre-market trading after gaining 6% on Friday.</li>
<li>NuZee, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUZE#NASDAQ">NUZE</a>) shares fell 16% to $1.37 in pre-market trading after jumping 34% on Friday.</li>
<li>Cyclacel Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) shares declined 13.3% to $1.30 in pre-market trading after declining over 5% on Friday.</li>
<li>Biodexa Pharmaceuticals Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>) shares fell 12.3% to $1.14 in pre-market trading. Biodexa shares jumped over 80% on Friday after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.</li>
<li>Nature Wood Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWGL#NASDAQ">NWGL</a>) shares fell 11.8% to $4.45 in pre-market trading after tumbling 70% on Friday.</li>
<li>mF International Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFI#NASDAQ">MFI</a>) shares declined 10.3% to $2.09 in pre-market trading after dipping around 78% on Friday.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38482020/investor-optimism-improves-following-earnings-reports-us-stocks-notch-weekly-gains">Investor Optimism Improves Following Earnings Reports; US Stocks Notch Weekly Gains</a>

Pre-Market Outlook

Movers

ADXN

AKAN

BDRX

Bakkt Holdings, Inc. Class A Common Stock

BKKT

CLVR

CYCC

FULT

IBRX

INHD

ISUN

NUZE

NWGL

OCEA

RYDE

SUUN

TSLA

WKEY

Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket

JMP Securities analyst Devin Ryan initiates coverage on Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) with a Market Outperform rating and announces Price Target of $70.

DAVE

JMP Securities Initiates Coverage On Dave with Market Outperform Rating, Announces Price Target of $70

Pudo reports FY results

Pudo net loss of C$0.21M, revenue of C$0.78M

Pudo net loss of C$0.33M, revenue of C$1.59M

Small Cap

Press Releases

PUDO Inc. reports FY 2023 results

PUDO Inc. reports FY 2024 first quarter end results

Wish Joins Forces with PUDO Inc. to Elevate Online Shopping Convenience for U.S. and Canada Shoppers

PUDO Inc. Joins Forces with Wish to Elevate Online Shopping Convenience for U.S. and Canadian Shoppers

PUDO Inc. reports FY 2024 second quarter end results

PUDO INC. REPORTS FY 2024 THIRD QUARTER END RESULTS

ReturnQueen and PUDO Inc. Announce Strategic Partnership to Revolutionize E-commerce Returns

PUDO Announces Resignation of COO

WISH

PUDO

With Gold And Silver On Fire, 23 Metals & Mining Executives Set To Give Investor Update This Week

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for PUDO Stock (OTC:PDPTF)

Wednesday, November 04, 2020

Wednesday, July 29, 2020